SSX6 Antibody Cat. No.: 25-337 SSX6 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human SSX6. TESTED APPLICATIONS: ELISA, WB SSX6 antibody can be used for detection of SSX6 by ELISA at 1:1562500. SSX6 antibody can APPLICATIONS: be used for detection of SSX6 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1211 - HepG2 Cell Lysate PREDICTED MOLECULAR 22 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by peptide affinity chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid October 2, 2021 1 https://www.prosci-inc.com/ssx6-antibody-25-337.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store SSX6 STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: SSX6 ALTERNATE NAMES: SSX6, dJ54B20.1, SSXP2, psiSSX2 ACCESSION NO.: NP_775493 PROTEIN GI NO.: 27659730 GENE ID: 280657 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint BACKGROUND: proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t (X;18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation. REFERENCES: 1) de (2007) Genes Chromosomes Cancer 46 (2), 107-117. ANTIBODIES FOR RESEARCH USE ONLY. For additional information, visit ProSci's Terms & Conditions Page. October 2, 2021 2 https://www.prosci-inc.com/ssx6-antibody-25-337.html.